INFLUENCIA DE LA ESTRATEGIA DE INMUNOSUPRESIÓN SOBRE EL DESARROLLO DE CÁNCER TRAS EL TRASPLANTE HEPÁTICO.

Datos básicos

Código:
MRP-TAC-2019-01
Protocolo:
MRP-TAC-2019-01
EUDRACT:
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
Año de incio:
2019
Año de finalización:
2020
ESTUDIO OBSERVACIONAL

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

MANUEL LUIS RODRÍGUEZ PERÁLVAREZ

Resultados del Ensayo Clínico


"Posttransplant calcineurin inhibitors levels and intra-patient variability are not associated with long term outcomes following liver transplantation".

Di Maira T; (...); Berenguer M

Article. 10.1097/TP.0000000000002987. 2020


A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area.

Carvalho-Gomes Â; (...); Berenguer M

Article. 10.1371/journal.pone.0228351. 2020

  • Open Access.

Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy forHelicobacter pyloriinfection: Spanish data of the EuropeanHelicobacter pyloriRegistry (Hp-EuReg)

Nyssen, OP; (...); Gisbert, JP

Article. 10.1111/hel.12722. 2020


Can endothelial biomarkers before liver transplantation together with classical cardiovasculat risk factors be useful to predict cardiovascular risk after liver transplantation

Herreras Lopez, Julia; (...); Aguilera Sancho, Victoria

Meeting Abstract. 2022


Can endothelial biomarkers before LT together with classical cardiovascular risk factors be useful to predict cardiovascular risk after LT?

Herreras, J.; (...); Aguilera, V.

Article. 2022


CMV reactivation (rCMV) is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplatatoin (LT)

Aguilera, V.; (...); Berenguer, M.

Meeting Abstract. 2023


CMV reactivation is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT)

Aguilera Sancho, Victoria; (...); Berenguer, Marina

Meeting Abstract. 2022


COVID vaccination among liver transplant recipients: A EASL-ESOT/ELITA-ILTS multi society survey

Vinaixa, Carmen; (...); Berenguer, Marina

Meeting Abstract. 2022


COVID-19 and liver transplantation

Di Maira T, Berenguer M

Editorial Material. 10.1038/s41575-020-0347-z. 2020

  • Open Access.

Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation

Rodriguez-Peralvarez, Manuel; (...); Gomez Bravo, Miguel Angel

Meeting Abstract. 2022

  • Open Access.

Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation.

Rodríguez-Perálvarez M; (...); Bernal-Bellido C

Article. 10.1111/ajt.17021. 2022

  • Open Access.

Cytomegalovirus reactivation is associated with lower hepatocelullar carcinoma recurrence rates after liver transplantation

Aguilera Sancho, Victoria; (...); Rodriguez-Peralvarez, Manuel

Meeting Abstract. 2023


Characteristics, trends and outcomes of liver transplantation (LT) for primary sclerosing cholangitis (PSC) in female patients: analysis of the European Liver Transplantation Registry (ELTR)

Di Maira, T; (...); European Liver & Intestine

Meeting Abstract. 2021


Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry

Berenguer M; (...); European Liver Intestine Transplan

Article. 10.1097/TP.0000000000003542. 2021


Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.

Chen Q; (...); Quer J

Article. 10.1016/j.antiviral.2019.104694. 2020

  • Open Access.

Efficacy of second-line regimens in SPain: Results from the EuroPean Registry on H. Pylori management (HP-EuReg)

Caldas, M; (...); Gisbert, JP

Meeting Abstract. 2019


European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain.

Caldas M; (...); Hp-EuReg Investigators

Article. 10.3390/antibiotics10010013. 2020

  • Open Access.

Everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study.

Gómez-Bravo M; (...); Santoyo J

Article. 10.17235/reed.2022.8549/2021. 2022

  • Open Access.

Frailty and Sarcopenia in Acute-on-Chronic Liver Failure

Renau, LP; (...); Berenguer M

Article. 10.1002/hep4.1722. 2021

  • Open Access.

Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS).

Russo FP; (...); Polak WG

Article. 10.1016/j.jhep.2021.09.041. 2021

  • Open Access.

HIV infection is not associated with increased cardiovascular (CV) risk in liver transplant (LT) recipients: a single centre comparative study

Vinaixa, C.; (...); Prieto, M.

Meeting Abstract. 2019


Immunosuppression in liver transplant.

Di Maira T, Little EC, Berenguer M

Review. 10.1016/j.bpg.2020.101681. 2020


IMPACT OF COMORBIDITIES ON LIVER TRANSPLANTATION: A PROSPECTIVE AND MULTICENTRIC ANALYSIS

Serrano, Trinidad; (...); Salcedo, Magdalena

Meeting Abstract. 2023


Impact of comorbidities on liver transplantation: a prospective and multicentric study

Serrano, Trinidad; (...); Salcedo, Magdalena

Meeting Abstract. 2022


Incidence and prognostic impact of cancer after liver transplantation

Rodriguez-Peralvarez, Manuel; (...); Angel Gomez-Bravo, Miguel

Meeting Abstract. 2020


Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcomes?

Herreras Lopez, Julia; (...); Aguilera, Victoria

Article. 10.17235/reed.2022.8384/2021. 2022

  • Open Access.

Milan-out Criteria and Worse Intention-to-Treat Outcome Postliver Transplantation.

Herreras J; (...); Berenguer M

Article. 10.1097/TXD.0000000000000934. 2019

  • Open Access.

Outcomes of re-referrals of patients with alcohol-associated liver disease, who were previously declined for liver transplantation.

Cox B; (...); Selzner N

Article. 10.1097/LVT.0000000000000274. 2023


Out-of-Milan HCC criteria and worse intention-to-treat results following liver transplantation

Herreras, J.; (...); Berenguer, M.

Meeting Abstract. 2019


Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.

Castelló B; (...); Berenguer M

Article. 10.1016/j.aohep.2019.06.014. 2019

  • Open Access.

Primary Sclerosing Cholangitis: Gender Effects in Valencia's Low-Prevalence Region.

Minguez, Alejandro; (...); Berenguer, Marina

Article. 10.1007/s10620-024-08368-y. 2024


Proceedings of the 29th Annual Congress of the International Liver Transplantation Society.

Patel, Madhukar S; (...); Rammohan, Ashwin

Article. 10.1097/LVT.0000000000000593. 2025


Re: Tacrolimus Trough Concentrations after Liver Transplantation: .

Di Maira T; (...); Berenguer M

Letter. 10.1097/TP.0000000000003087. 2020

  • Open Access.

Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain.

Manuel Sousa J; (...); Manzanares A

Article. 10.1371/journal.pone.0225061. 2019

  • Open Access.

Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments

Giuliani, Tommaso; (...); Lopez-Andujar, Rafael

Article. 10.1159/000539460. 2024


Simple score to assess cardiovascular risk post-liver transplantation

Di Maira, T; (...); Berenguer, M

Meeting Abstract. 2021


SIMPLE SCORE TO ASSESS CARDIOVASCULAR RISK POST-LIVER TRANSPLANTATION

Di Maira, Tommaso; (...); Berenguer, Marina

Meeting Abstract. 2022


Single-capsule bismuth-quadruple therapy: 3 or 4 times daily? Spanish Data from the European Registry on H. pylori Management (Hp-EuReg)

Nyssen, OP; (...); Calvet, X

Meeting Abstract. 2019


THE IMPACT OF DIRECT ACTING ANTIVIRALS ON HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION: A MULTICENTRIC RETROSPECTIVE STUDY

Gorgen, A; (...); Sapisochin, G

Meeting Abstract. 2019


The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study

Gorgen, A; (...); Sapisochin, G

Article. 10.1097/TP.0000000000003115. 2020


THE PRESENCE OF METABOLIC SYNDROME BEFORE TRANSPLANTATION INCREASE THE RISK OF CARDIOVASCULAR EVENTS FOLLOWING LIVER TRANSPLANTATION

Herreras, J; (...); Aguilera, V

Meeting Abstract. 2021


Trends in liver transplantation for acute liver failure. A Spanish multicenter study

Conde, Isabel; (...); Berenguer, Marina

Meeting Abstract. 2022


Trends in liver transplantation for acute liver failure: a Spanish multicenter study

Conde, I.; (...); Berenguer, M.

Meeting Abstract. 2022


Very early immunosuppression predicts the first-year renal function post liver transplantation

Di Maira, T.; (...); Berenguer, M.

Meeting Abstract. 2019


Very low access to early liver transplantation (LT) for acute alcoholic hepatitis (AAH) in a setting of social psychiatric contraindications

Garcia Garcia, S.; (...); Aguilera, V.

Meeting Abstract. 2023


Worldwide variations in COVID-19 vaccination policies and practices in liver transplant settings: results of a multi-society global survey.

Di Maira, Tommaso; (...); Berenguer, Marina

Article. 10.3389/frtra.2023.1332616. 2023


Campos de estudio

Compartir